Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
CD4+ lymphocyte count \<100cells/mm3 at the screening visit.
Documented history of HIV infections
Must have received stable, combination anti HIV drugs for at least 4 months immediately prior to participation, and per the investigator, are unlikely to require change in anti-HIV drugs during the six-month study.
Laboratory confirmation of genital herpes (a positive Herpes Simplex Virus-2 antibody test).
3 or more outbreaks of genital herpes in the previous 12 months if not on genital herpes medicines currently.
3 or more outbreaks of genital herpes per year in the period prior to beginning of treatment for chronic genital herpes.
You may not be if
Kidney diseases.
Liver diseases.
Known allergic reactions to VALTREX (valaciclovir), ZOVIRAX (acyclovir), FAMVIR (famciclovir), or CYTOVENE (ganciclovir).
Vomiting syndrome.
Must be willing to discontinue taking current genital herpes medicines 1 week prior to participation.
Active AIDS-indicator conditions, as defined by CDC Category C.
